), a leading provider of healthcare products for women, is
currently showcasing some of its latest offerings at the 38th
Arab Health Congress at the Dubai International Convention and
Exhibition Centre. The company undertook this marketing
initiative mainly to attract potential customers from the
Middle-East. The conference is likely to host 83,000 medical
experts from 142 countries.
Some of the Hologic's products displayed at the conference
include market leading 2D and 3D mammography systems (Selenia
Dimensions) for breast tomosynthesis, the SecurView diagnostic
workstation, and the Atec breast biopsy system. Also featured are
the Panther system and the associated Aptima assay, which were
inducted into Hologic's portfolio with the acquisition of
Gen-Probe in August 2012.
The ThinPrep Pap Test and ThinPrep Imaging systems for
cervical cancer screening featured at the event are the driving
factor behind growth in the company's Diagnostics business. These
apart, Hologic's Discovery bone densitometry platform, NovaSure
endometrial ablation system and MyoSure tissue removal device are
also on display.
In an effort to expand its global reach, Hologic is building
on its international infrastructure and fortifying management
resources, particularly in the emerging markets of China, Latin
America, the Middle East and Eastern Europe. In fiscal 2012, the
company generated 27% of its revenues from international
As a part of its growth strategy to focus on international
markets and the Middle East, the company is opening a new office
in Dubai Healthcare City. The office is scheduled to open in the
first quarter of 2013.
However, over the past few quarters, Hologic witnessed several
challenges in the form of economic uncertainties in Europe,
slower sales cycles and increasing pricing pressure. Moreover,
fluctuating foreign currency might adversely affect its
international revenues and operating results, particularly in the
Diagnostics segment, which has maximum exposure to international
The stock carries a Zacks Rank #3, which translates into a
short-term Hold rating. Medical instrument companies, such as
Cantel Medical Corp.
Delcath Systems, Inc.
) with Zacks Rank #1 (Strong Buy), are expected to do well.
CANTEL MED CORP (CMN): Free Stock Analysis
CYBERONICS INC (CYBX): Free Stock Analysis
DELCATH SYS INC (DCTH): Free Stock Analysis
HOLOGIC INC (HOLX): Free Stock Analysis
To read this article on Zacks.com click here.